1-methyl-4-phenyl-2,3-dihydropyridinium and pentoxifylline

1-methyl-4-phenyl-2,3-dihydropyridinium has been researched along with pentoxifylline in 1 studies

Compound Research Comparison

Studies (1-methyl-4-phenyl-2,3-dihydropyridinium)	Trials (1-methyl-4-phenyl-2,3-dihydropyridinium)	Recent Studies (post-2010) (1-methyl-4-phenyl-2,3-dihydropyridinium)	Studies (pentoxifylline)	Trials (pentoxifylline)	Recent Studies (post-2010) (pentoxifylline)
46	0	3	4,437	657	943

Protein Interaction Comparison

Protein	Taxonomy	1-methyl-4-phenyl-2,3-dihydropyridinium (IC50)	pentoxifylline (IC50)
Acetylcholinesterase	Homo sapiens (human)		6.6

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Gwizdek-Wiśniewska, A; Piosik, J; Ulanowska, K; Wegrzyn, G	1

Other Studies

1 other study(ies) available for 1-methyl-4-phenyl-2,3-dihydropyridinium and pentoxifylline

Article	Year
Impaired mutagenic activities of MPDP(+) (1-methyl-4-phenyl-2,3-dihydropyridinium) and MPP(+) (1-methyl-4-phenylpyridinium) due to their interactions with methylxanthines. Bioorganic & medicinal chemistry, 2007, Aug-01, Volume: 15, Issue:15 Topics: 1-Methyl-4-phenylpyridinium; Caffeine; Calorimetry; Drug Interactions; Models, Molecular; Molecular Structure; Mutagens; Pentoxifylline; Pyridinium Compounds; Spectrophotometry, Atomic; Vibrio	2007

Article

Year

Impaired mutagenic activities of MPDP(+) (1-methyl-4-phenyl-2,3-dihydropyridinium) and MPP(+) (1-methyl-4-phenylpyridinium) due to their interactions with methylxanthines.

Bioorganic & medicinal chemistry, 2007, Aug-01, Volume: 15, Issue:15

Topics: 1-Methyl-4-phenylpyridinium; Caffeine; Calorimetry; Drug Interactions; Models, Molecular; Molecular Structure; Mutagens; Pentoxifylline; Pyridinium Compounds; Spectrophotometry, Atomic; Vibrio

2007